Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.69, Iss.1, 2009-02, pp. : 8-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer’s amyloid precursor protein β-secretase

Cytogenetic and Genome Research, Vol. 89, Iss. 3-4, 2000-08 ,pp. : 177-184

Karger

Access to resources Recommend Favorite

A canine model of Alzheimer's disease generated by overexpressing a mutated human amyloid precursor protein

International Journal of Molecular Medicine, Vol. 33, Iss. 4, 2014-01 ,pp. : 1003-1012

Spandidos Publications

Access to resources Recommend Favorite

Recent Approaches Targeting Beta-Amyloid for Therapeutic Intervention of Alzheimer's disease

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 222-233

Bentham Science Publishers

Access to resources Recommend Favorite

Serum levels of albumin‐β complexes

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 14, Iss. 3, 2014-07 ,pp. : 716-723

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is targeting beta-amyloid pathology, with immunotherapy, an effective treatment option for Alzheimer's disease?

Reviews in Clinical Gerontology, Vol. 21, Iss. 4, 2011-11 ,pp. : 340-345

Cambridge University Press

Access to resources Recommend Favorite